Diagnosis and treatment of complex fibroadenoma

doi:10.3877/cma.j.issn.1674-0793.2018.01.017

Abstract

Abstract:

The prevalence of breast malignancy has been increasing rapidly in China nowadays. Among the numerous inducements of breast cancer, whether fibroadenoma related to breast cancer has been the controversy, especially for complex fibroadenoma. This article mainly focuses on the risk of developing breast carcinoma, the diagnosis and treatment of complex fibroadenoma, providing evidence for the correct treatment of breast fibroadenoma.

Key words: Breast neoplasms, Fibrocystic breast disease, Fibroadenoma

Xiongxiong Li, Lizhe Zhu, Can Zhou, Yu Ren. Diagnosis and treatment of complex fibroadenoma[J]. Chinese Archives of General Surgery(Electronic Edition), 2018, 12(01): 61-64.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhptwkxwx.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0793.2018.01.017

https://zhptwkxwx.cma-cmc.com.cn/EN/Y2018/V12/I01/61

References 20

[1]	Dupont WD, Page DL, Parl FF, et al. Long-term risk of breast cancer in women with fibroadenoma[J]. N Engl J Med, 1994, 331(1): 10-15.
[2]	Greenberg R, Skornick Y, Kaplan O, et al. Management of breast fibroadenomas[J]. J Gen Intern Med, 1998，13(9): 640-645.
[3]	Cant PJ, Madden MV, Coleman MG, et al.Non-operative management of breast masses diagnosed as fibroadenoma[J]. Br J Surg, 1995，82(6): 792-794.
[4]	El-Wakeel H, Umpleby HC. Systematic review of fibroadenoma as a risk factor for breast cancer[J]. Breast, 2003，12(5): 302-307.
[5]	Nassar A, Visscher DW, Degnim AC, et al. Complex fibroadenoma and breast cancer risk: a Mayo Clinic Benign Breast Disease Cohort Study[J]. Breast Cancer Res Treat, 2015, 153(2): 397-405.
[6]	Kabat GC, Jones JG, Olson N, et al. A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer[J]. Cancer Causes Control, 2010，21(6): 821-828.
[7]	Kuijper A, Mommers EC, van der Wall E, et al. Histopathology of fibroadenoma of the breast[J]. Clin Pathol, 2001，115(6): 736-742.
[8]	Sklair-Levy M, Sella T, Alweiss T, et al. Incidence and management of complex fibroadenomas[J]. AJR Am J Roentgenol, 2008，190(1): 214-218.
[9]	Lim WK, Ong CK, Tan J, et al. Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma[J]. Nat Genet, 2014，46(8): 877-880.
[10]	Kalderon AE, Diner WC. Carcinoma arising in a long-standing fibroadenoma[J]. Am J Diagn Gynecol Obstet, 1979，1(3): 269-273.
[11]	Pick PW, Iossifides IA. Occurrence of breast carcinoma within a fibroadenoma. A review[J]. Arch Pathol Lab Med, 1984，108(7): 590-594.
[12]	Shinde SR, Jussawalla DJ. Lobular carcinoma arising in a fibroadenoma[J]. Surg Oncol, 1982, 20(1): 59-61.
[13]	Schnitt SJ. Benign breast disease and breast cancer risk: morphology and beyond[J]. Am J Surg Pathol, 2003，27(6): 836-841.
[14]	Leconte I, Abraham C, Galant C, et al. Fibroadenoma: can fine needle aspiration biopsy avoid short term follow-up?[J]. Diagn Interv Imaging, 2012, 93(10): 750-756.
[15]	Pinto J, Aguiar AT, Duarte H, et al. Simple and complex fibroadenomas：are there any distinguishing sonographic features?[J]. Ultrasound Med, 2014, 33(3): 415-419.
[16]	Lee KH, Kim SJ, Park YM, et al. Gray-scale and color Doppler sonographic features of complex fibroadenomas of the breast[J]. J Clin Ultrasound, 2015，43(9): 556-562.
[17]	National Comprehensive Cancer Network. Breast cancer screening and diagnosis[EB/OL].[2013-12-02]. URL
[18]	Cant PJ, Madden MV, Close PM, et al. Case for conservative management of selected fibro-adenomas of the breast[J]. Br J Surg, 1987, 74(9): 857-859.
[19]	Marcon M, Frauenfelder T, Beckera AS, et al. First ultrasound diagnosis of BI-RADS 3 lesions in young patients: Can 6-months follow-up be sufficient to assess stability?[J]. Eur J Radiol, 2017, 89: 226-233.
[20]	Gordon PB. Solid breast masses diagnosed as fibroadenoma at fine-needle aspiration biopsy: acceptable rates of growth at long-term follow-up[J]. Radiology, 2003，229(1): 233-238.

Please choose a citation manager

Content to export